These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 8941654

  • 21. Anti-acetylcholine receptor idiotypes in myasthenia gravis analysed by rabbit anti-sera.
    Lang B, Roberts AJ, Vincent A, Newsom-Davis J.
    Clin Exp Immunol; 1985 Jun; 60(3):637-44. PubMed ID: 4017289
    [Abstract] [Full Text] [Related]

  • 22. Acetylcholine receptor antibody characteristics in myasthenia gravis. Fractionation of alpha-bungarotoxin binding site antibodies and their relationship to IgG subclass.
    Whiting PJ, Vincent A, Newsom-Davis J.
    J Neuroimmunol; 1983 Aug; 5(1):1-9. PubMed ID: 6874919
    [Abstract] [Full Text] [Related]

  • 23. Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin.
    Vernet-der Garabedian B, Bach JF, Morel E.
    Clin Exp Immunol; 1987 Apr; 68(1):130-7. PubMed ID: 3652512
    [Abstract] [Full Text] [Related]

  • 24. IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
    Blaes F, Beeson D, Plested P, Lang B, Vincent A.
    Ann Neurol; 2000 Apr; 47(4):504-10. PubMed ID: 10762162
    [Abstract] [Full Text] [Related]

  • 25. Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity.
    Vernet-der Garabedian B, Eymard B, Bach JF, Morel E.
    J Neuroimmunol; 1989 Jan; 21(1):41-7. PubMed ID: 2908881
    [Abstract] [Full Text] [Related]

  • 26. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J, Wray DW, Pizzighella S, Hall Z, Vincent A.
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of Maternal-to-Fetal Transfer of IgG Antibodies by FcRn Blockade in a Mouse Model of Arthrogryposis Multiplex Congenita.
    Coutinho E, Jacobson L, Shock A, Smith B, Vernon A, Vincent A.
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 34045306
    [Abstract] [Full Text] [Related]

  • 28. Anti-MuSK patient antibodies disrupt the mouse neuromuscular junction.
    Cole RN, Reddel SW, Gervásio OL, Phillips WD.
    Ann Neurol; 2008 Jun; 63(6):782-9. PubMed ID: 18384168
    [Abstract] [Full Text] [Related]

  • 29. Antibodies identified by cell-based assays in myasthenia gravis and associated diseases.
    Vincent A, Waters P, Leite MI, Jacobson L, Koneczny I, Cossins J, Beeson D.
    Ann N Y Acad Sci; 2012 Dec; 1274():92-8. PubMed ID: 23252902
    [Abstract] [Full Text] [Related]

  • 30. Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis.
    MacLennan C, Beeson D, Buijs AM, Vincent A, Newsom-Davis J.
    Ann Neurol; 1997 Apr; 41(4):423-31. PubMed ID: 9124798
    [Abstract] [Full Text] [Related]

  • 31. Characterization of an anti-fetal AChR monoclonal antibody isolated from a myasthenia gravis patient.
    Saxena A, Stevens J, Cetin H, Koneczny I, Webster R, Lazaridis K, Tzartos S, Vrolix K, Nogales-Gadea G, Machiels B, Molenaar PC, Damoiseaux J, De Baets MH, Simon-Keller K, Marx A, Vincent A, Losen M, Martinez-Martinez P.
    Sci Rep; 2017 Oct 31; 7(1):14426. PubMed ID: 29089519
    [Abstract] [Full Text] [Related]

  • 32. Asymptomatic maternal myasthenia as a cause of the Pena-Shokeir phenotype.
    Brueton LA, Huson SM, Cox PM, Shirley I, Thompson EM, Barnes PR, Price J, Newsom-Davis J, Vincent A.
    Am J Med Genet; 2000 May 01; 92(1):1-6. PubMed ID: 10797415
    [Abstract] [Full Text] [Related]

  • 33. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
    Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A.
    Nat Med; 2001 Mar 01; 7(3):365-8. PubMed ID: 11231638
    [Abstract] [Full Text] [Related]

  • 34. Arthrogryposis multiplex congenita. Review with comment.
    Hageman G, Willemse J.
    Neuropediatrics; 1983 Feb 01; 14(1):6-11. PubMed ID: 6339980
    [Abstract] [Full Text] [Related]

  • 35. Isolation of acetylcholine receptor-like protein from fetal calf thymus.
    Kawanami S, Yuki M, Oda K, Goto I, Kuroiwa Y.
    Biochem Int; 1984 Mar 01; 8(3):377-83. PubMed ID: 6477609
    [Abstract] [Full Text] [Related]

  • 36. Treatment of antenatal myasthenia gravis.
    Carr SR, Gilchrist JM, Abuelo DN, Clark D.
    Obstet Gynecol; 1991 Sep 01; 78(3 Pt 2):485-9. PubMed ID: 1870801
    [Abstract] [Full Text] [Related]

  • 37. Detection and characterization of blocking-type anti-acetylcholine receptor antibodies in sera from patients with myasthenia gravis.
    Hara H, Hayashi K, Ohta K, Itoh N, Nishitani H, Ohta M.
    Clin Chem; 1993 Oct 01; 39(10):2053-7. PubMed ID: 8403390
    [Abstract] [Full Text] [Related]

  • 38. Isolation and characterization of human anti-acetylcholine receptor monoclonal antibodies from transgenic mice expressing human immunoglobulin loci.
    Protopapadakis E, Kokla A, Tzartos SJ, Mamalaki A.
    Eur J Immunol; 2005 Jun 01; 35(6):1960-8. PubMed ID: 15915538
    [Abstract] [Full Text] [Related]

  • 39. Maternal myasthenia gravis: a cause for arthrogryposis multiplex congenita.
    Midelfart Hoff J, Midelfart A.
    J Child Orthop; 2015 Dec 01; 9(6):433-5. PubMed ID: 26482518
    [Abstract] [Full Text] [Related]

  • 40. Arthrogryposis multiplexa congenita: an epidemiologic study of nearly 9 million births in 24 EUROCAT registers.
    Hoff JM, Loane M, Gilhus NE, Rasmussen S, Daltveit AK.
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec 01; 159(2):347-50. PubMed ID: 22005589
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.